Sectors
The life sciences research technology developer has received funding in a series A round co-led by corporate investor ABclonal.
The healthcare engagement technology provider has received $12m in a round co-led by the Blue Cross Blue Shield-backed Blue Venture Fund.
The medical documentation tool developer has been acquired by Nuance Communications having raised $7.5m from investors including NewYork-Presbyterian.
Phable, developer of a chronic disease assistance app, has secured funding in a round led by healthcare provider Manipal Hospitals.
Access Biotechnology returned for a round that will push Day One Biopharmaceuticals' paediatric drug candidate through a phase 2 study.
The AAA, CSAA, Microsoft and Motorola Solutions-backed emergency response software developer’s latest round, led by Insight Partners, brought its total funding to $200m.
The round brought the total raised by the oncology diagnostics technology developer, backed by Bristol Myers Squibb, Helsinn and Inova Health, to $244m.
Existing strategic investor Allogene Therapeutics has taken part in an $85m series A round for Notch Therapeutics, which is working on cancer treatments.
The WuXi AppTec-backed round will help the hepatitis B drug developer begin human trials for its lead drug candidate.
GV returned for SpyBiotech's $32.5m series A round, as it looks to move its first potential vaccine into the clinic by early next year.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
